Publikacje


Antidepressant activity of fluoxetine in the zinc deficiency model in rats involves the NMDA receptor complex. Urszula Doboszewska, Bernadeta Szewczyk, Magdalena Sowa-Kućma, Katarzyna Młyniec, Anna Rafało, Beata Ostachowicz, Marek Lankosz, Gabriel Nowak
Behavioural brain research, 10.1016/j.bbr.2015.03.064 S0166-4328(15)00236-3
PMID:25845739

Czwartek, 7 Maja 2015
Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists. Katarzyna Młyniec, Magdalena Gaweł, Gabriel Nowak
Behavioural brain research, 10.1016/j.bbr.2015.03.053 S0166-4328(15)00218-1
PMID:25827929

Czwartek, 7 Maja 2015
A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives. Petronille Bogaert, Tomasz Bochenek, Anna Prokop, Andrzej Pilc
PloS one, 10.1371/journal.pone.0125691
PMID:25942432

Środa, 6 Maja 2015
Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Joanna Kryst, Paweł Kawalec, Andrzej Pilc
PloS one, 10.1371/journal.pone.0124279
PMID:25933004

Sobota, 2 Maja 2015
Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action. Gabriel Nowak
Pharmacological reports : PR, 10.1016/j.pharep.2015.01.015 S1734-1140(15)00027-4
PMID:25933983

Sobota, 2 Maja 2015
Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice. Małgorzata Wolak, Agata Siwek, Bernadeta Szewczyk, Ewa Poleszak, Beata Bystrowska, Andrzej Moniczewski, Anita Rutkowska, Katarzyna Młyniec, Gabriel Nowak
Pharmacological reports : PR, 10.1016/j.pharep.2014.12.003 S1734-1140(14)00374-0
PMID:25933959

Sobota, 2 Maja 2015
The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies. Marek Bednarski, Magdalena Dudek, Joanna Knutelska, Leszek Nowiński, Jacek Sapa, Małgorzata Zygmunt, Gabriel Nowak, Magdalena Luty-Błocho, Marek Wojnicki, Krzysztof Fitzner, Maciej Tęsiorowski
Pharmacological reports : PR, 10.1016/j.pharep.2014.10.019 S1734-1140(14)00331-4
PMID:25933945

Sobota, 2 Maja 2015
mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Joanna M Wierońska, Natalia Kłeczek, Monika Woźniak, Piotr Gruca, Magdalena Łasoń-Tyburkiewicz, Mariusz Papp, Piotr Brański, Grzegorz Burnat, Andrzej Pilc
Neurochemistry international, 10.1016/j.neuint.2015.03.010 S0197-0186(15)00061-3
PMID:25863284

Środa, 8 Kwietnia 2015
Pregabalin for the treatment of social anxiety disorder. Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, Gabriel Nowak
Expert opinion on investigational drugs, 10.1517/13543784.2014.979283
PMID:25361817

Piątek, 13 Marca 2015
Ergotamine and nicergoline - facts and myths. Paweł Zajdel, Marek Bednarski, Jacek Sapa, Gabriel Nowak
Pharmacological reports : PR, 10.1016/j.pharep.2014.10.010 S1734-1140(14)00322-3
PMID:25712664

Środa, 25 Lutego 2015